Solid Tumours
- PMID: 32091819
- Bookshelf ID: NBK554012
- DOI: 10.1007/978-3-030-02278-5_92
Solid Tumours
Excerpt
In the absence of randomized prospective trials, the EBMT registry remains an important source to survey indications, outcome and clinical risk factors in patients with solid tumours treated by auto- and allo-HSCT.
Copyright 2019, EBMT and the Author(s).
Sections
References
-
- Admiraal R, van der Paardt M, Kobes J, et al. High-dose chemotherapy for children and young adults with stage IV rhabdomyosarcoma. Cochrane Database Syst Rev. 2010;12:CD006669. - PubMed
-
- Bode U, Zimmermann M, Moser O, et al. Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial. J Neuro-Oncol. 2014;120:635–42. - PubMed
-
- Boye K, Del Prever AB, Eriksson M, et al. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study. Pediatr Blood Cancer. 2014;61:840–5. - PubMed
-
- Bregni M, Badoglio M, Pedrazzoli P, Lanza F. Is allogeneic transplant for solid tumors still alive? Bone Marrow Transplant. 2016;51:751–2. - PubMed
Publication types
LinkOut - more resources
Full Text Sources